41372-20-7

• 常用中文名：阿朴吗啡
• 常用英文名：R-(-)-Apomorphine
• CAS号：41372-20-7
• 分子式：C₁₇H₂₀ClNO₃
• 分子量：321.79900
• 相关类别： 原料药 消化系统用药 其它消化系统用药
• 发布时间：2018-04-06 08:00:00
• 更新时间：2024-01-03 08:15:10
• 【用途一】
  本品是一种催吐药物。

名称

• 中文名: 阿朴吗啡
• 英文名: apomorphine hydrochloride
• 中文别名: (R)-(-)-阿朴吗啡盐酸盐半水; (R)-5,6,6a,7-四氢-6-甲基-4H-二苯并[de,g]喹啉-10,11-二醇
• 英文别名: (R)-Apomorphine Hydrochloride Hemihydrate; EINECS 206-243-0; R-(-)-Apomorphine; Apomorphine hydrochloride hemihydrate; MFCD00150904; R-(−)-Apomorphine hydrochloride hemihydrate; Apomorphine (hydrochloride hemihydrate)

物化性质

• 密度: 1.299 g/cm3
• 沸点: 473.4ºC at 760 mmHg
• 熔点: 285-287 °C(lit.)
• 分子式: C₁₇H₂₀ClNO₃
• 分子量: 321.79900
• 闪点: 268.8ºC
• 精确质量: 321.11300
• PSA: 52.93000
• LogP: 3.52550
• 外观性状: 灰色结晶粉末
• 储存条件:

  本品应密封避光保存。

• 计算化学:

  1、 疏水参数计算参考值（XlogP）：未确定

  2、 氢键供体数量：7

  3、 氢键受体数量：7

  4、 可旋转化学键数量：0

  5、 拓扑分子极性表面积（TPSA）：88.4

  6、 重原子数量： 43

  7、 表面电荷： 0

  8、 复杂度：374

  9、 同位素原子数量：0

  10、 确定原子立构中心数量：2

  11、 不确定原子立构中心数量：0

  12、 确定化学键立构中心数量：0

  13、 不确定化学键立构中心数量：0

  14、 共价键单元数量：5

• 更多:

  1. 性状：白色细结晶性粉末。无臭。露光及在空气中能分解并变为绿色。

  2. 密度（g/mL,25/4℃）：未确定

  3. 相对蒸汽密度（g/mL,空气=1）：未确定

  4. 熔点（ºC）：未确定

  5. 沸点（ºC,常压）：未确定

  6. 沸点（ºC,5.2kPa）：未确定

  7. 折射率：未确定

  8. 闪点（ºC）：未确定

  9. 比旋光度（º,c=1.2）：－48°

  10. 自燃点或引燃温度（ºC）：未确定

  11. 蒸气压（kPa,25ºC）：未确定

  12. 饱和蒸气压（kPa,60ºC）：未确定

  13. 燃烧热（KJ/mol）：未确定

  14. 临界温度（ºC）：未确定

  15. 临界压力（KPa）：未确定

  16. 油水（辛醇/水）分配系数的对数值：未确定

  17. 爆炸上限（%,V/V）：未确定

  18. 爆炸下限（ %,V/V ）：未确定 19. 溶解性： 1g 产品溶于 50ml 冷水、 17ml80 ℃ 的热水、 50ml 乙醇，极微溶于氯仿和乙醚 。

MSDS

Section 1. Chemical Product and Company Identification Apomorphine Hydrochloride, hemihydrateCatalog Common Name/ Number(s). Trade Name CAS# Apomorphine Hydrochloride, hemihydrate Section 3. Hazards Identification Hazardous in case of ingestion, of inhalation (lung sensitizer). Slightly hazardous in case of skin contact (irritant, Potential Acute Health sensitizer), of eye contact (irritant). Effects CARCINOGENIC EFFECTS: Not available. Potential Chronic Health MUTAGENIC EFFECTS: Mutagenic for bacteria and/or yeast. Effects TERATOGENIC EFFECTS: Not available. DEVELOPMENTAL TOXICITY: Not available. The substance may be toxic to kidneys, gastrointestinal tract, central nervous system (CNS). Repeated or prolonged exposure to the substance can produce target organs damage. Section 4. First Aid Measures Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least Eye Contact 15 minutes. Cold water may be used. Get medical attention if irritation occurs. Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops. Skin Contact Cold water may be used. Not available. Serious Skin Contact If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get Inhalation medical attention. Not available. Serious Inhalation Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an Ingestion unconscious person. If large quantities of this material are swallowed, call a physician immediately. Loosen tight clothing such as a collar, tie, belt or waistband. Not available. Serious Ingestion Section 5. Fire and Explosion Data Flammability of the Product May be combustible at high temperature. Auto-Ignition Temperature Not available. Not available. Flash Points Not available. Flammable Limits These products are carbon oxides (CO, CO2), nitrogen oxides (NO, NO2...), halogenated compounds. Products of Combustion Fire Hazards in Presence of Slightly flammable to flammable in presence of heat. Non-flammable in presence of shocks. Various Substances Slightly explosive in presence of open flames and sparks. Explosion Hazards in Non-explosive in presence of shocks. Presence of Various Substances SMALL FIRE: Use DRY chemical powder. Fire Fighting Media LARGE FIRE: Use water spray, fog or foam. Do not use water jet. and Instructions As with most organic solids, fire is possible at elevated temperatures Special Remarks on Fire Hazards Fine dust dispersed in air in sufficient concentrations, and in the presences of an ignition source is a potential dust Special Remarks on explosion hazard. Explosion Hazards Apomorphine Hydrochloride, hemihydrate Section 6. Accidental Release Measures Use appropriate tools to put the spilled solid in a convenient waste disposal container. If necessary: Neutralize the Small Spill residue with a dilute solution of sodium carbonate. Finish cleaning by spreading water on the contaminated surface and dispose of according to local and regional authority requirements. Use a shovel to put the material into a convenient waste disposal container. Neutralize the residue with a dilute Large Spill solution of sodium carbonate. Finish cleaning by spreading water on the contaminated surface and allow to evacuate through the sanitary system. Section 7. Handling and Storage Keep away from heat. Keep away from sources of ignition. Do not breathe dust. Wear suitable protective clothing. Precautions In case of insufficient ventilation, wear suitable respiratory equipment. If you feel unwell, seek medical attention and show the label when possible. Keep away from incompatibles such as oxidizing agents, alkalis. Keep container tightly closed. Keep container in a cool, well-ventilated area. Sensitive to light. Store in Storage light-resistant containers. Air Sensitive Section 8. Exposure Controls/Personal Protection Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below Engineering Controls recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants below the exposure limit. Personal ProtectionSafety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Gloves. Personal Protection in Case Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE of a Large Spill handling this product. Not available. Exposure Limits Section 9. Physical and Chemical Properties Solid. (Crystalline powder.)Odorless. Physical state andO dor appearance Not available. Taste 312.8 g/mole Molecular Weight White. Off-white. Color 4 - 5[Acidic.] pH (1% soln/water) Not available. Boiling Point 195°C (383°F) Melting Point Not available. Critical Temperature Not available. Specific Gravity Not applicable. Vapor Pressure Not available. Vapor Density Not available. Volatility Not available. Odor Threshold Not available. Water/Oil Dist. Coeff. Not available. Ionicity (in Water) See solubility in water. Dispersion Properties Soluble in cold water. Solubility Slightly soluble in diethyl ether. Solubility in water: 20 g/l Insoluble in chloroform. Apomorphine Hydrochloride, hemihydrate Section 10. Stability and Reactivity Data The product is stable. Stability Not available. Instability Temperature Conditions of Instability Excess heat, incompatible materials, dust generation Incompatibility with various Reactive with oxidizing agents, alkalis. substances Not available. Corrosivity Air and light sensitive. Special Remarks on Incompatible with iodides, tannin, iron salts Reactivity Not available. Special Remarks on Corrosivity Will not occur. Polymerization Section 11. Toxicological Information Inhalation. Ingestion. Routes of Entry Acute oral toxicity (LD50): 300 mg/kg [Mouse]. Toxicity to Animals Chronic Effects on Humans MUTAGENIC EFFECTS: Mutagenic for bacteria and/or yeast. May cause damage to the following organs: kidneys, gastrointestinal tract, central nervous system (CNS). Other Toxic Effects onHazardous in case of ingestion, of inhalation (lung sensitizer). HumansSlightly hazardous in case of skin contact (irritant, sensitizer). Not available. Special Remarks on Toxicity to Animals May affect genetic material (mutagenic). Special Remarks on Chronic Effects on Humans May cause adverse reproductive effects based on animal test data Special Remarks on otherAcute Potential Health Effects: Toxic Effects on HumansSkin: Skin contact may cause redness, irritation and sensitization. Absorption through skin (e.g. by subcutaneous injection will produce systemic and central nervous symtpoms similar that of ingestion or inhalation. Eyes: May cause redness, and irritation. Inhalation: Inhalation of dust may cause sensitization, asthma, and respiratory tract irritation. Inhalation of dust may also cause nausea, and vomiting, and may affect behavior/central nervous system (symptoms similar to that of ingestion) Ingestion: May be harmful if swallowed. Causes gastrointestinal tract irritation with abdominal pain, nausa, vomiting and diarrhea. May affect behavior/central nervous system and cause stimulation and depression of the central nervous system. Symptoms may include restlessness, euphoria, drowsiness or sleepiness, yawning, somnolence, dizziness, sedation, cognitive impairment, personality change, lightheadedness, tremors, confusion, halllucinations, coma/unconsciousness. Other symptoms may include pin point or dilated pupils, respiratory depression, postural hypotension, sore throat, increased cough, rhihitis, flushing, taste disorder, sweating, circulatory failure, death. It may also affect the kidneys. Chronic Potential Health Effects: Ingestion or Skin Absorption/Subcutaneous injection: Prolonged or repeated ingestion or exposure by subcutaneous injection may have systemic and nervous system symptoms similar to that of acute ingestion or inhalation and affect the kidneys, adrenal gland and cause loss of appetite/weight loss. Section 12. Ecological Information Not available. Ecotoxicity Not available. BOD5 and COD Products of Biodegradation Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise. Apomorphine Hydrochloride, hemihydrate The products of degradation are more toxic than the product itself. Toxicity of the Products of Biodegradation Not available. Special Remarks on the Products of Biodegradation Section 13. Disposal Considerations Waste DisposalWaste must be disposed of in accordance with federal, state and local environmental control regulations. Section 14. Transport Information Not a DOT controlled material (United States). DO T Cl assi fi cati on Not applicable. Identification Not applicable. Special Provisions for Transport DO T (Pi ctograms) Section 15. Other Regulatory Information and Pictograms No products were found. Federal and State Regulations California prop. 65: This product contains the following ingredients for which the State of California has found to California cause cancer which would require a warning under the statute: No products were found. Proposition 65 Warnings California prop. 65: This product contains the following ingredients for which the State of California has found to cause birth defects which would require a warning under the statute: No products were found. Not available. Other Regulations WHMIS (Canada) Not controlled under WHMIS (Canada). Other Classifications R20/22- Harmful by inhalation and ifS24- Avoid contact with skin. DSCL (EEC) swallowed.S36/37- Wear suitable protective clothing and R42/43- May cause sensitization bygloves. inhalation and skin contact.S46- If swallowed, seek medical advice immediately and show this container or label. Health Hazard HMIS (U.S.A.)2 National Fire Protection 1 Flammability 1 Association (U.S.A.) Fire Hazard 2 0 Reactivity Health Reactivity 0 Specific hazard Personal ProtectionE WHMIS (Canada) (Pictograms) Apomorphine Hydrochloride, hemihydrate DSCL (Europe) (Pictograms) TDG(Canada) (Pictograms) ADR (Europe) (Pictograms) Protective Equipment Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. SECTION 16 - ADDITIONAL INFORMATION N/A

毒性和生态

生态学数据: 对水是稍微有危害的不要让未稀释或大量的产品接触地下水、水道或者污水系统，若无政府许可，勿将材料排入周围环境

安全

• 符号: GHS06
• 信号词: Danger
• 危害声明: H301
• 警示性声明: P301 + P310
• 个人防护装备: dust mask type N95 (US);Eyeshields;Faceshields;Gloves
• 危害码 (欧洲): Xn: Harmful;
• 风险声明 (欧洲): R22
• 安全声明 (欧洲): S36
• 危险品运输编码: UN 2811 6.1/PG 3
• WGK德国: 3

制备

由吗啡经消除、重排、成盐而得。将吗啡加入磷酸中，水浴加热，内温不超过50℃。搅拌至全溶。冷却置于吸收罐内，通入氯化氢气体至反应液重达吗啡量的2.5倍。将其移入反应罐内，继续通入氯化氢气体，同时加热至124-126℃，保温反应3小时。将反应液放入冰水中，冷至20℃以下，搅拌下慢慢加入碳酸钠至胶状物析出完全为止。分取胶状物加入浓盐酸中，在沸水中溶解胶状物盐酸盐，再加入亚硫酸钠溶液中，用二氯乙烷-异丙醇混合溶媒提取2次。提取液于搅拌下加入浓盐酸，析出粗品。将所得粗品用浓盐酸浸泡、热蒸馏水溶解、加活性炭脱色、真空干燥等步骤便得到成品。